Format

Send to

Choose Destination
Clin Genet. 2018 Apr;93(4):812-821. doi: 10.1111/cge.13170. Epub 2018 Feb 12.

Variants in CIB2 cause DFNB48 and not USH1J.

Author information

1
Department of Otolaryngology, Head and Neck Surgery, Molecular Otolaryngology and Renal Research Laboratories, University of Iowa, Iowa City, IA, USA.
2
Interdisciplinary Graduate Program in Molecular Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
3
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
4
John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
5
Division of Pediatric Genetics, Ankara University School of Medicine, Ankara, Turkey.
6
Institut Pasteur, Génétique et Physiologie de l'Audition, Paris, France.
7
John P. Hussman Institute for Human Genomics, Dr. John T. Macdonald Foundation Department of Human Genetics, Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL, USA.

Abstract

The genetic, mutational and phenotypic spectrum of deafness-causing genes shows great diversity and pleiotropy. The best examples are the group of genes, which when mutated can either cause non-syndromic hearing loss (NSHL) or the most common dual sensory impairment, Usher syndrome (USH). Variants in the CIB2 gene have been previously reported to cause hearing loss at the DFNB48 locus and deaf-blindness at the USH1J locus. In this study, we characterize the phenotypic spectrum in a multiethnic cohort with autosomal recessive non-syndromic hearing loss (ARNSHL) due to variants in the CIB2 gene. Of the 6 families we ascertained, 3 segregated novel loss-of-function (LOF) variants, 2 families segregated missense variants (1 novel) and 1 family segregated a previously reported pathogenic variant in trans with a frameshift variant. This report is the first to show that biallelic LOF variants in CIB2 cause ARNSHL and not USH. In the era of precision medicine, providing the correct diagnosis (NSHL vs USH) is essential for patient care as it impacts potential intervention and prevention options for patients. Here, we provide evidence disqualifying CIB2 as an USH-causing gene.

KEYWORDS:

CIB2; DFNB48; USH1J; Usher syndrome; deafness; non-syndromic hearing loss

PMID:
29112224
PMCID:
PMC5851821
[Available on 2019-04-01]
DOI:
10.1111/cge.13170

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center